Impact of Patient Visualization of Cardiovascular Images on Modification of Cardiovascular Risk Factors: A Meta-Analysis.

[1]  J. Lindholt,et al.  Cost effectiveness of population screening versus no screening for cardiovascular​ disease: the Danish Cardiovascular Screening trial (DANCAVAS). , 2022, European heart journal.

[2]  J. Lindholt,et al.  Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial. , 2022, The New England journal of medicine.

[3]  G. Watts,et al.  Impact of a coronary artery calcium-guided statin treatment protocol on cardiovascular risk at 12 months: Results from a pragmatic, randomised controlled trial. , 2021, Atherosclerosis.

[4]  M. Kivimäki,et al.  Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study , 2021, The Lancet. Digital health.

[5]  P. Wester,et al.  The beneficial effect over 3 years by pictorial information to patients and their physician about subclinical atherosclerosis and cardiovascular risk: Results from the VIPVIZA randomized clinical trial , 2021, American journal of preventive cardiology.

[6]  Jennifer G. Robinson,et al.  Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy. , 2021, Circulation. Cardiovascular quality and outcomes.

[7]  A. Bengtsson,et al.  Increased knowledge makes a difference! – general practitioners’ experiences of pictorial information about subclinical atherosclerosis for primary prevention: an interview study from the VIPVIZA trial , 2021, Scandinavian journal of primary health care.

[8]  R. Pettigrew,et al.  Coronary artery calcium scoring: an evidence‐based guide for primary care physicians , 2020, Journal of internal medicine.

[9]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[10]  G. Watts,et al.  Coronary artery calcium scoring in cardiovascular risk assessment of people with family histories of early onset coronary artery disease. , 2020, The Medical journal of Australia.

[11]  M. Johnston,et al.  Behaviour Change Techniques Associated with Smoking Cessation in Intervention and Comparator Groups of Randomised Controlled Trials: A Systematic Review and Meta-Regression. , 2020, Addiction.

[12]  Lifeng Lin,et al.  P-value driven methods were underpowered to detect publication bias: analysis of Cochrane review meta-analyses. , 2019, Journal of clinical epidemiology.

[13]  M. Henein,et al.  Imaging subclinical atherosclerosis promises better cardiovascular primary prevention , 2019, European journal of preventive cardiology.

[14]  H. D. de Koning,et al.  Impact of a cardiovascular disease risk screening result on preventive behaviour in asymptomatic participants of the ROBINSCA trial , 2019, European journal of preventive cardiology.

[15]  J. Rocklöv,et al.  Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial , 2019, The Lancet.

[16]  Jinkwon Kim,et al.  Effect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in Korea , 2018, Cardiovascular Diabetology.

[17]  V. Fuster,et al.  Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors. , 2017, Journal of the American College of Cardiology.

[18]  M. Budoff,et al.  The Identification of Calcified Coronary Plaque Is Associated With Initiation and Continuation of Pharmacological and Lifestyle Preventive Therapies: A Systematic Review and Meta-Analysis. , 2017, JACC. Cardiovascular imaging.

[19]  Wendy S. Post,et al.  Comparison of Carotid Plaque Score and Coronary Artery Calcium Score for Predicting Cardiovascular Disease Events: The Multi‐Ethnic Study of Atherosclerosis , 2017, Journal of the American Heart Association.

[20]  Andy McEwen,et al.  National guidelines for smoking cessation in primary care: a literature review and evidence analysis , 2017, npj Primary Care Respiratory Medicine.

[21]  E. Boerwinkle,et al.  Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. , 2016, The New England journal of medicine.

[22]  J. Hallas,et al.  The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial , 2015, Trials.

[23]  H. Bøtker,et al.  Visualization of Coronary Artery Calcification: Influence on Risk Modification. , 2015, The American journal of medicine.

[24]  M. Gulanick,et al.  Does Knowledge of Coronary Artery Calcium Affect Cardiovascular Risk Perception, Likelihood of Taking Action, and Health-Promoting Behavior Change? , 2015, The Journal of cardiovascular nursing.

[25]  N. Sattar,et al.  The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice. , 2014, Atherosclerosis. Supplements.

[26]  O. Franco,et al.  Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. , 2014, JAMA.

[27]  J. Cornuz,et al.  Impact of carotid plaque screening on smoking cessation and other cardiovascular risk factors: a randomized controlled trial. , 2012, Archives of internal medicine.

[28]  S. Peters,et al.  Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review , 2011, Heart.

[29]  Daniel S Berman,et al.  Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. , 2011, Journal of the American College of Cardiology.

[30]  J. Schwartz,et al.  Health behavior modification after electron beam computed tomography and physician consultation , 2010, Journal of Behavioral Medicine.

[31]  P. O'Malley,et al.  Community-based provision of statin and aspirin after the detection of coronary artery calcium within a community-based screening cohort. , 2008, Journal of the American College of Cardiology.

[32]  R. Blumenthal,et al.  Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors. , 2008, The American journal of cardiology.

[33]  Matthew J Budoff,et al.  Expert review on coronary calcium , 2008, Vascular health and risk management.

[34]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[35]  M. Budoff,et al.  Visualizing coronary calcium is associated with improvements in adherence to statin therapy. , 2006, Atherosclerosis.

[36]  P. O'Malley,et al.  Impact of electron beam tomography, with or without case management, on motivation, behavioral change, and cardiovascular risk profile: a randomized controlled trial. , 2003, JAMA.

[37]  G. Diamond,et al.  Does coronary artery screening by electron beam computed tomography motivate potentially beneficial lifestyle behaviors? , 1996, The American journal of cardiology.